Published online Jun 6, 2022. doi: 10.12998/wjcc.v10.i16.5515
Peer-review started: February 25, 2022
First decision: April 18, 2022
Revised: April 20, 2022
Accepted: May 5, 2022
Article in press: May 5, 2022
Published online: June 6, 2022
Processing time: 97 Days and 4.9 Hours
Major depressive disorder is a serious and common neuropsychiatric disorder that affects more than 350 million people worldwide. Electroconvulsive therapy is the oldest and most effective treatment available for the treatment of severe major depressive disorder. Electroconvulsive therapy modifies structural network changes in patients with major depressive disorder and schizophrenia. And it can also affect neuroinflammatory responses and may have neuroprotective effects. Electroconvulsive therapy plays an irreplaceable role in the treatment of major depressive disorder.
Core Tip: Electroconvulsive therapy has been shown to be very useful for the acute treatment of major depressive, manic, and mixed states, especially those with a high degree of suicide, as well as catatonic and drug-resistant depression. It should not be seen as a second line of defense after drug therapy.
